Michael J. LaBarre

Former Senior Vice President, Chief Technical OfficeratHalozyme Therapeutics· In proxies 2021–2025

Pay in FY2025-32% from the year before · Halozyme Therapeutics stock +40.8% the same year

Michael J. LaBarre was paid $2.1M in FY2025 (Dec), down 32%. Halozyme Therapeutics stock rose 40.8% that year.

Pay$100 in the stock at the end of FY20 → $158

Pay is from the Summary Compensation Table of each Halozyme Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

HALO
Halozyme TherapeuticsPublic company · 5 yr
- Former Senior Vice President, Chief Technical Officer2021 – Present · 5 yrStock in role +203%

Roles come from the proxy statements of each company.

Activity

Pay
Halozyme Therapeutics Former Senior Vice President, Chief Technical Officer pay fell 32% to $2.1M. The stock rose 41% in FY2025 (Dec).
DEF 14AMar 23, 2026
Pay
Halozyme Therapeutics Former Senior Vice President, Chief Technical Officer pay rose 37% to $3.1M. The stock rose 42% in FY2022 (Dec).
DEF 14AMar 15, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?